Serum HER-2/neu change predicts clinical outcome to trastuzumab-based therapy.

被引：0
|
作者：
Ali, S. M.
Esteva, F. J.
Fornier, M.
Gligorov, J.
Harris, L.
Kostler, W. J.
Luftner, D.
Pichon, M. F.
Tse, C.
Lipton, A.
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
[2] Lebanon VAMC, Lebanon, PA USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Tenon Hosp, Paris, France
[6] Yale Univ, New Haven, CT 06520 USA
[7] Univ Hosp Vienna, Vienna, Austria
[8] Humboldt Univ, Berlin, Germany
[9] Biol Specialiste Ctr Lutte Contre, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3S / 3S
页数：1
相关论文
共 50 条
  • [1] Serum HER2/neu change predicts clinical outcome to trastuzumab-based therapy
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1094 - +
  • [2] Decline in serum HER-2/neu predicts response to trastuzumab-based therapy
    Ali, S. M.
    Brault, D.
    Brown-Shimer, S.
    Carney, W.
    Esteva, F. J.
    Fornier, M.
    Gligorov, J.
    Hamer, P.
    Harris, L.
    Kostler, W. J.
    Leitzel, K.
    Lotz, J. P.
    Luftner, D.
    Pichon, M. F.
    Thiel, R. P.
    Tse, C.
    Wheler, J.
    Lipton, A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (01): : 75 - 76
  • [3] Decline in serum HER-2/neu predicts response to trastuzumab-based therapy
    Leitzel, K.
    Esteva, F.
    Fornier, M.
    Gligorov, J.
    Harris, L.
    Kostler, W.
    Luftner, D.
    Pichon, M.
    Tse, C.
    Lipton, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 102 - 102
  • [4] Serum HER-2/NEU decline predicts improved response to trastuzumab-based therapy (serum HER-2/NEU study group)
    Ali, S. M.
    Esteva, F. J.
    Fornier, M.
    Harris, L.
    Kostler, W. J.
    Lotz, J. P.
    Luftner, D.
    Pichon, M. F.
    Tse, C.
    Lipton, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 69 - 69
  • [5] Serum HER-2/neu decline predicts improved response to trastuzumab-based therapy in patients with normal and elevated baseline serum HER-2/neu levels.
    Ali, S. M.
    Brault, D.
    Brown-Shimer, S.
    Carney, W.
    Esteva, F. J.
    Fornier, M.
    Gligorov, J.
    Hamer, P.
    Harris, L.
    Leitzel, K.
    Kostler, W.
    Lotz, J-P
    Luftner, D.
    Pichon, M-F
    Thiel, R. P.
    Tse, C.
    Wheler, J.
    Lipton, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S90 - S90
  • [6] Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer
    Köstler, WJ
    Steger, GG
    Soleiman, A
    Schwab, B
    Singer, CF
    Tomek, S
    Brodowicz, T
    Krainer, M
    Wiltschke, C
    Horvat, R
    Jakesz, R
    Zielinski, CC
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1127 - 1130
  • [7] Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
    Ali, Suhail M.
    Carney, Walter P.
    Esteva, Francisco J.
    Fornier, Monica
    Harris, Lyndsay
    Koestler, Wolfgang. J.
    Lotz, Jean-Pierre
    Luftner, Diana
    Pichon, Marie-France
    Lipton, Allan
    CANCER, 2008, 113 (06) : 1294 - 1301
  • [8] Changes in serum HER-2/neu levels of >20% from baseline is associated with favorable clinical outcomes to Trastuzumab-based therapy
    Price, C.
    Ali, S.
    Harris, L.
    Brault, D.
    Kostler, W.
    Luftner, D.
    Fornier, M.
    Leitzel, K.
    Lotz, J. P.
    Pichon, M.
    Lipton, A.
    Thiel, R. P.
    Esteva, F.
    Tse, C.
    Carney, W. P.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A115 - A115
  • [9] Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer
    Köstler, WJ
    Schwab, B
    Singer, CF
    Neumann, R
    Rücklinger, E
    Brodowicz, T
    Tomek, S
    Niedermayr, M
    Hejna, M
    Steger, GG
    Krainer, M
    Wiltschke, C
    Zielinski, CC
    CLINICAL CANCER RESEARCH, 2004, 10 (05) : 1618 - 1624
  • [10] HER-2 therapy. HER-2/neu diagnostics in breast cancer
    Walter P Carney
    Kim Leitzel
    Suhail Ali
    Rainer Neumann
    Allan Lipton
    Breast Cancer Research, 9
12345